NORD Webinar: Life After Gene Therapy

There was so much interest in my posting about new drugs for sickle cell disease (SCD) I thought it would be helpful to amplify the future of managing SCD. Today NORD continues its gene therapy education series with a webinar reviewing what happens post gene therapy. One of the participants is managing SCD.   Although this is pretty late notice you can view the archived webinar series on the NORD @ www.rarediseases.org. To register and join the webinar click here – https://bit.ly/38PLd3y